The World Health Organization has laid down its first guidelines for GLP-1 drugs like Wegovy and Zepbound. Advertisement.

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...

Experts say the official recommendation reemphasizes the game-changing ability of GLP-1 medications, but stress that diet and exercise are integral to an effective treatment plan for obesity. The ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...

For the best results, medications like Ozempic and Zepbound should be combined with exercise and healthy eating habits.

The WHO has just released landmark global guidelines recommending for the first time that GLP-1 medicines may be used for long-term treatment of obesity in adults. The move comes as obesity rates ...

Designed to be an ally for your nutritional goals, they’re gluten-free, low-glycemic and keto-friendly with 3 grams of net carbs and 1 gram of sugar per serving. Experts recommend making sure you’re ...

GLP-1 is a hormone that plays a key role in glucose metabolism and appetite regulation Obesity affects more than one billion people worldwide. To address this growing health challenge, the World ...

The World Health Organisation (WHO) has released a guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic disease. In September 2025, the WHO added GLP-1 ...

American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by ...

Medications for obesity may improve fertility, but there are many unknowns when it comes to using them during pregnancy.